The minimize in paclitaxel CL noticed during the presence of zosuquidar led to a increase in some time the plasma paclitaxel concentration remains higher than 0.1 mol L−1, which is understood to get a marker of equally toxicity (neutropenia) and efficacy [1]. Although the impact of zosuquidar on the toxicity https://branchd332oal5.webdesign96.com/profile